Consensus IDI

Equities

Market Closed - Euronext Paris Other stock markets 16:55:00 13/05/2026 BST			5-day change	1st Jan Change
72.00 ^EUR	+0.56%		-0.28%	+4.65%

04-05	IDI announces Annual dividend, payable on May 28, 2026	CI
04-01	IDI: IDI is investing its own money only, with success	AL

673f.45FlIMG6knAEdrpcrcogEA8A8VsvhVTg35v_1MSr4LI.sKlIerj14zhzHvY-3KtHYjhIuwsZ0yaxucqcspD9uOCK-ilJteLQOFAl2Q~f17c7b3e25a736d31cce35291ddb8430

04-01	IDI: IDI is investing its own money only, with success	AL
11-14	IDI: IDI back on the front foot	AL
25/09/25	IDI: IDI enters a new gear	AL
26/03/25	IDI: IDI: Private equity access with shareholder focus	AL
29/11/24	IDI: Steady dividend growth reflects IDI's robust model	AL
14/11/24	IDI: Q3-24: Navigating 2024 with a thoughtful investment approach	AL
25/09/24	IDI: Nothing to rattle IDI	AL
15/03/24	IDI: FY23: IDI rewards its shareholders	AL
28/11/23	IDI : Ending Q3 with firepower at its peak	AL
26/10/23	IDI : Adjustment following the completion of the sale of Flex Composite Group	AL
28/09/23	IDI : Masters the value creation playbook	AL
26/09/23	IDI : Shielded against macro-economic turmoil	AL
25/09/23	Oddo BHF Lifts IDI PT, Maintains Outperformance Rating	MT
25/09/23	IDI: Oddo BHF raises its target price
04/09/23	IDI : Adjustment following Omnes acquisition	AL
20/06/23	IDI: share price up, broker raises target
20/06/23	Oddo BHF Boosts IDI's PT, Affirms Outperformance Recommendation	MT
20/06/23	IDI: Oddo BHF raises its target price
19/06/23	IDI : IDI forges ahead in 2023 with solid divestments	AL
26/05/23	IDI: Oddo BHF raises its target price
13/04/23	IDI : FY22: IDI in a solid stand amidst an adverse environment	AL
11/01/23	IDI : Faced with macroeconomic woes, IDI proves resilient	AL
14/09/22	IDI : H1 22: a new milestone for IDI	AL
14/09/22	IDI : H1 22: a new milestone for IDI	AL
06/09/22	IDI : Revision to EPS expectations in view of the challenges ahead	AL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Objective/dr gap
IDI		-	+11.03%
EQT AB			+24.37%
PARTNERS GROUP HOLDING AG			+30.87%
CVC CAPITAL PARTNERS PLC			+29.2%
ONEX CORPORATION			+32.98%
BRIDGEPOINT GROUP PLC			+46.91%
RATOS AB			+25.44%
MEDCAP AB	-	-	+16.95%
INVESTCORP CAPITAL PLC			+28.59%
ALARIS EQUITY PARTNERS INCOME TRUST			+19.38%
Average			+26.57%
Weighted average by Cap.			+28.25%